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Clinical and in vitro evidence suggest that pretreatment of 
skin with a drug or vehicle can influence topical drug 
delivery. In this study, hairless mouse skin in diffusion cells 
was treated for 48 h with topical applications of vehicle 
al.one (oleic acid (OA), isopropyl myristate, octanol (OCT), 
dimethylformamide, propylene g lycol (PG), ethylene gly-
col (EG), formamide) , or mixtures of OA and PG, or with 
5-f1uorouracil (5-FU) suspensions in each of these vehicles. 
Twenty-four hours after removing the initially applied agent, 
a standard suspension of theophylline in PG was applied 
to the sk in surface and the flux of theophylline was deter-
mined over the next 48 h. Skin pretreatment with vehicle 
alone increased theophylline flu x 1.6- (EG) to 122-fold (OCT) 
T here is a large am ount of c1in. ica l and in vivo evidence to suggest that pretreatment of skin with, o r repeated applica tions with, a drug or vehicle can influence sub-sequent topical drug delivery. In fact, choice of ve-hicles m ay be m ade to en han ce percutaneous absorp-
tion by effects of the vehicle on hydration or on the barrier function 
(stratum corneum) of the skin rl,21. 
The hairless mouse skin in vitro diffusion cell m ethod is an 
es tablished system for the study of percutaneous absorption [3,4]. 
In recent studies of a predictive model for penetration of the-
ophylline and sa li cy lic acid from different vehicles using this hair-
less mouse skin diffusion m ethod, Sloan et al [5 ,6] also looked 
at the effects of pretrea tment of the skin in vitro on subsequent 
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over contro l experim ents in which the skins were not pre-
treated. Pretreatment with nonpolar vehicles with lower 
solubili ty parameters (OA, OCT, or mixed vehicles con-
taining one of these) had the greates t effect on subseguent 
theophylline flux. 
Pretreatment with 5-FU in various vehicles ca used a sub-
seguent in creased theophylline flux similar to the effect of 
vehicle alone, except for pretreatment with 5-FU in ve-
hicles which did not have much effect themselves. In those 
instances, theophylline flu xes up to 16-fold over the effect 
of those vehicles alone were observed.) Invest Dermato! 89: 
249-252, 1987 
topical app lication and flu x of a solute/solvent, i. e. , theophyllin e 
in propylene g lycol (T fPC). In those studies, Sloan and coworkers 
found that the choice of drug (theophylline vs sa li cyli c acid) in a 
g iven vehicle for the first application made a difference regarding 
effects on the skin and flux of the subseq uentl y applied T /PC. 
Recently, our laboratory has studied the flu x of5-flu orouracil (5-
FU) in va rio us vehicles using the sa m e predictive model [7] and 
we beca me interested in trying to separate vehicle effects on the 
skin barrier to permeation froni partitioning effects on permea-
tion. In this study we assess the effect of pretreatment of hairless 
mouse skin in vitro with (a) various vehicles alone and (b) 5-FU 
in the vehicles on the flu x of th eophylline from a standa rd sus-
pension in propylene g lycol (PG) . A further aim was to try to 
sepa rate vehicle effects from drug + vehicle effects on the skin 
to the penetration of a subseq uentl y applied drug. 
MATERIALS AND METHODS 
Materials The theophylline, 5-FU , and o leic acid (OA) were 
o btained from Sigma C hemi cal Co., St. Louis, Missouri. The 
isopropyl myristate (IPM) was obta ined from Givaud an Corp., 
C lifton, N ew Jersey . The remaining vehicles were obtained from 
Aldrich (Milwaukee, Wisconsin) and were aU >99% pure . The 
diffusion ce!ls used (3 cm in diameter, 7.06 cm 2 surface area, 40 
ml receptor volum~) were obtained from Kercso Engineering 
Consultants, Palo Alto, California. A Labline incubator w ith Var-
iomag stirrer was used to maintain constant temperature at 32°C 
and to stir the receptor phase of the cells. A Shimadzu UV -1 60 
spectrophotometer was used for recordin g UV spectra. The 18-28 
g female hairless mi ce (SKH-hr-l) were ob tained from Temple 
University Skin and Cancer Hospital, Philadelphia, Pennsylvania. 
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Diffusi'on Cell Studies 
Preparalioll ami Ill iliai Appiica/ioll (PrCireallllcliI ): Mi cc were sac-
rificed by ccrvica l dislocation . The full-thickness skin was re-
moved and the middorsal area was imm ediately placcd on dif-
fusion cell s in contac t w ith the receptor phase, w hich 'was 0.05 
M phosphate buffer (p H 7.3 at 32°q co ntai nin g 0. 1 % vlv of36% 
aq ueous formaldehyde as a preservative. The ski n preparations 
wen: kept in contac t w ith the buffer for 48 h to allow any wa ter-
soluble UV-absorbing materials to k ach fro m the skin. Three 
changes of the rcceptor phase were m adc during this period. At 
48 h th e receptor pluses we rc changed with fresh buffcr and 0.5-
ml ali quots of a vehicle or a suspcnsion of 5-F U in a vehicle were 
applicd to th e donor sides of each skin surface. T he 5-FU sus-
pensions had been prepared by stirring 400 mg of 5-FU in 5 ml 
of veh icle [800 m g/5 ml for dimeth ylformamidc (DMF)] for 48 
h at rOom tempera ture. Three diffusion cells were run for each 
vehicl e or 5-FU suspension . 
For cells to w hi ch 5-FU suspens ions were applied , 3-ml sa mples 
from the receptor phase we re taken at 3, 6, 9, 12, 18, 21, 24, 30, 
36, and 48 h for determination of flux of 5-FU (UV'llOX = 265 
nm , extin ctio n coefficicnt = 7.13 X 103 litcrs/ mo l). Threc milli-
liters of bu ffcr was replaced each time. For cells to which o nl y 
the vehicl es were appli ed, no samples were taken during this 48-
h pcriod. The data for this first phasc experiment for 5-FU flu x 
were reported by Sherertz and Sloa n [7J. The 48-h pretreatment 
tim e for the vehicles was used to be consistent w ith previous 
work by Sloan 's g roup [5,6], and to corrcspond to the 5-FU/vehicie 
flu x study. 
Was /10111 Pilase alld Seco lld Applicat ioll: At 96 h (48 h afte r the 
appli ca tion of the first donor phase), thc donor phases were re-
moved by gentl y washin g the skin s 3 timcs w ith 10 ml of m eth-
anol, keeping the tota l skin contact tim e w ith the methanol to a 
minimum «3 min) . Although it is probable that l1l cth anolmay 
remove .so m e of the lipid of the stratum co rneum , prev ious studies 
have shown that the stratum co rn eum is still intact by li ght mi-
croscopy afte r methanol wash [5], and the flux of theophylline 
in PG was only sli ghtl y differcnt throu gh skin prewashed with 
methanol co mpared with sk in w hi ch had not been subj ected to 
this wash [6]. The receptor phases were changed and the skins 
were kept in contact with fresh buffer for 23 h to allow any 
residu al 5-FU in the skin to diffuse into th e recepto r phase. At 
23 h, 3-ml sa mples of the receptor phases were taken for UV 
spectrophotometric analys is; then the en tire recepto r phases were 
changed . Twenty-four hours afte r the first donor phases were 
removed (120 h total) , the receptor phases were sa m pled and 
changcd aga in , thcn a 0.5-m1 aliquot of a theo phylline suspens ion 
in propylene g lycol (T/PG, 400 m g/6 ml) was app lied to each of 
the diffusion cells. Samples were taken from the receptor phase 
after 1, 2, 3, 6, 12, 24, and 48 h fo r analys is of the amount of 
theophylline by UV spectroscopy. Control cxperiments in wh ich 
the ski ns were kept in contact w ith thc bu ffe r for 120 h, w ith a 
mcthanol wash of the skins 24 h prior to application of the T / PG 
suspension were also done, as previously described [5]. 
. The amou nt of theophylline in the recepto r phase samples was 
measured from UV absorbances at 270 nm (exti nction coefficicnt 
= 1.02 X 104 liters/ m o l). Thc analys is of each subsequent sa mple 
was co rrected for the rcm ova l of theophylline fro lll all previous 
sa mples. C umul ative milli g ram s of theoph ylline in th e recepto r 
phase werc plotted aga inst tim e. Linear rcgression analysis was 
used to obtain slopcs of these plots of m g aga inst h. Co rrelation 
coefficients were at least r = 0.99. In these experiments w here 
the sk ins were pretreated w ith 5-FU /vchicJe o r vehicle alone, the 
theophylline flux appea red to occur ill a sin gle phase. Slopes were 
determined for the linea r portion of each plot, w hich varied from 
the 1-6 h o r 1-24 h sa mpl es depending on the vehicle used in 
pretreatment. Representative graphs of cumulati ve milligrams of 
theophy lline delivered through skin vs time after pretreatment of 
th e skin w ith DMF, lPM , o r OA/PC (1 :3) are shown in Fig 1. 
Fluxes were then obtained by di vidin g th e slopes by the skin 
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Figure 1. Plots of Cllillula ti v~ milligra Jlls o f theophylline diffused through 
hairless mouse skins fro m propylene g lyco l suspensions vs tim e, afrer the 
skins had been pr~treated w ith a rep resentative ve hicle. Vehicle used for 
pretreatment: OA/ PG ( 1 :3) (()Petllrioll.~ / es). II'M (closed circles) . DMF (opw 
sq ll orcs). 
surface area (7 .06 cm2). Statisti ca l analysis was done usin g the 
two-sample I test. 
RESULTS 
The effect of time alo ne bctween preparation of a hairless mouse 
skin in the diffusion cells and appli cat io n ofT/PG had bcen pre-
vio usly shown to have no signifi ca nt effect on flu x [5]. In those 
contro l expe rim ents, the skin was in co ntact w ith buffer 2-1 20 
h befo re application of the T I PG . The m ethanol wash procedure 
itsclfhad a minim al but signifi cant effect on the subseq ucnt T / PG 
flux . Under the conditions of the current stud y, a flu x for T / PG 
of7.0 X 10 - 3 m g/ cm 2h , after the ski ns we re kept in contact with 
buffer for '120 h and th e ski ns were washed with methanol at 96 
h, was used as the control value. This value is different fro m the 
previously reported contro l for T I PG flux of2.4 X 10 - 3 m g/ cm2h 
va lue [5], possibly beca use the ambi ent temperature as well as the 
receptor phase was kept at 32°C in the currcnt experiment. 
T he results of the flu x of theoph yll ine from propylene g lycol 
throu gh hai rless m ouse skin in diffusion cells after pretreatment 
of the sk in w ith a vehicle alone o r a suspension of 5-FU in a 
vchicle arc sllmmarizcd ill Table I. T hc res ults indi cate that pre-
treat ment of the skin wi th vehicle alo ne increases the flu x ofT/ PG 
approximately 1.6- (c th ylen e glycol, EC) to 122- fold (octanol. 
OCT) over the flu x obtai ned for T / PC in the contro l ex periment. 
Vehicles which werc more nonpolar and w hich exh ibited lower 
solubility parameters (O A, OCT, IPM, and mixed vehicles con-
tainin g OA or OCT) had the g rcatest effect on subseq uent T / PG 
flux . Pretrea tm ent of the skin s w ith 5-FU in the various vehicle 
resulted in the observa tion of th e same trend of enhancin g later 
T I PC flux. This en hancemcnt was si milar in m agnitude to the 
effect of vehicle alone in most cases, except for the situ atio il whcre 
th e vehicle alo ne had minima l effect. For exa mple , 5-FU in DMF 
and in EC ca used a subseq uent in crease in T / PG flu x appro,,;-
matcly 16- fo ld over th e effect of those ve hi cles alone. 
Table II shows the rat ios of theophylline flux after skin pre-
treatl11ent to contro l theophylline flu x to compare th e current 
results w ith those previously obtained for skin pretreatment with 
either theop hylline [5] o r sali cylic ac id [6] in th osc vehicles . Pre-
treatm ent of sk in with either sa li cyli c ac id or 5-FU in vehicle 
had a grea ter effeer on in creasin g later T I PC flux than d id pre-
trea tm en t w ith theoph ylline in simil ar vehicles. Again , the di f-
ference is most no table w ith the dru gs in those vehicles (e. g., PG. 
formamidc (FORM), EG) w here the vehicl es thcmselves did not 
grea tl y enhance T / PG flux . 
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Table I. Effect of Pretreatm ent of H airless M ouse Sk in With Vehi cles o r 5-Fluo rourac il in Vehicles on Subsequ ent 
Theophylline/ Propylene G lycol Flux" 
Theoph yllinc FI LI X ± SD x 10' (Ill g/ cm"h) 
Skin Prctrcatmcnt 
Vchiclc Alo ll c" 5-FU in Vehicle' 
PretrCJtl11CIH Vehi cle FILl x ± 51) I-lo llI's" Fili x ± SI) H ours" 
Control" 7 ± 3 ( 1. 5) 
Dimcthylforl11 'll11idc 8 ± 4 1. 2 132 ± 13 U.9 
(D MF) 
Propy lene g lyco l (pG) 18 ± 5 1.1 54 ± 1 2.8 
E th ylene g lyco l (EG) 11 ± 2 U.9 169 ± 28 2.0 
Forlll amidc: (FORM ) 17 ± 7 0.9 3 1 ± 20 1.6 
Isopropyl m yri state (I PM) 134 ± 7 0.7 237 ± 74 ? -_ .J 
Oleic acid (OA) 694 ± 53 0.3 676 ± 17U 0.0 
OA / PG ( I : I) 11 32 ± 122 0. 14 643 ± 80 0.0 
OA / PG ( I :3) 853 ± 44 0.3 725 ± 40 0.0 
OA / PG (1 : 14.5) 79 1 ± 29 0.3 595 ± 30 0. 1 
Octa nol (OCT) 856 ± 102 0.0 727 ± 26 U.O 
OCT / PG ( I : I) 54 1 ± 42 0.0 484 ± 23 0.0 
"n = 3. 
"The Auxes o f th eop hyll in e after DMF. PG. EG. or FO IHvl pretrea tm ent arc no t signi fi cantl y diffe rent from each orher o r co ntro l. The Aux es after OA. OCT . mi xed 
OA/ PG o r OCT/ PG vell ick- pretreat lltent are no t signifi ca ntl y d iffcrclH fro l11 t..'::lch orba . 
'T he Au xes o f th eophylline after 5-FU in vehicle pretreat ment arc all diffe rent fro m L'ach o ther at the Ji < 0.005 level excep t for EG vs DM F, and mi xed vchicles vs each 
m her. OCT. o r OA. 
JColl tro l: 120 h prcincub:uioll o f skin conracr wi th bll frlT ill fC..'ccpror ph:l. sc . w it'h n1l.: 111 :1I1 0 1 w:-Is h :l frcr 96 h. There was nO vchick- a ll the donor sidL', 
tLag tillle in hours. 
The effect of pretrea tm ent of the ski n w ith OA-PG mi xed 
vehicles showed that th e addition of 0 small am ount of OA to 
PG (1: 14.5) g reatl y enhanced subsequent T / PG Au x over the 
fluxes seen w ith no pretreatment or w ith prio r application of PG 
alone. 
D ISCUSS ION 
Fu ndam ental to dermatolog ic topical therapy are the concep ts of 
using a vehicle to inAuence drug delivery b y either in creasing 
hydra tio n of th e stratum co rn eum, o r by optimi zin g partitioning 
of th e dru g into th e skin [1,2] . O ther studies lookin g at the effects 
of dru g rea ppli ca tio n to the skin mos tl y consider the stratum 
co rneum rese rvoir o r tachyph ylax is due to drug effects, and mos t 
in vitro studies of drug penetration ha ve been done on sin gle dose 
a pplications [8]. In a recent eva luation of the effect of repea ted 
da ily skin appli ca ti ons on th e abso rpti o n o f so li cy li c acid in a rat 
model, Roberts and Horlock [91 noted an initi al in crease in Aux 
of sa licyli c acid fo ll owed in 2 days by a decrea se in flu x. Those 
autho rs suggested that the initial dru g ap pli ca tion altered th e skin 
barrier fun ction and led to altered penetration for th e subsequ entl y 
applied sa li cy li c ac id 19]. Bucks, Maibach, and G uy fl 01 found 
no signifi ca nt change in hum an skin penetrati on of topi ca l stero ids 
with n:pcatcd appli ca tion, w hi ch is som ewhat differen t fro m the 
animal m odel studies 19,111. Few studies have looked at the effect 
of skin pretreatment w ith a vehicle alone on subsequent dru g 
penetrat ion. B lank and M cA uliffe 11 21 in vest iga ted the change in 
perm ea bility constants for benzene and tritiated water before and 
after hum an skin pretreatment with va rious lipop hili c vehi cles 
(gasoline, hexa ne, butano l) vs 0. 1% sod ium chlo ride Or water in 
vitro. They found that different vehicles appeared to a lter polar 
and no npo lar perm eo bility path ways diffe rentl y [1 2]. Wester et 
al 111 J found no enh anced penetration of hydrocortison e after 
monk ey skin pretreatment w ith acetone vehi cle alo ne. The pen-
e[!'atio n enhan cer Azone h as been found to be m ore effecti ve in 
in creasing the in vit ro skin penetration oftriAuoro th ymidine fro m 
PG o r po lye th ylene g lyco l ifit was used to pretrea t th e skin rath er 
than if it wa s in co rporated in to th e vehicle itself[1 3]. N o rationale 
fo r the mechanism of this effect of Azone pretrea tment was sug-
ges ted . 
Table II. Hatios of Theophylline Flux After Skin Pret rea tm ent Versus Contro l T heophylline Flu x" 
Vehicle 
Dimerh ylform amidc 
Propylene g lyco l (PG) 
Ethylenc g lyco l 
Forl11al1lidc 
Isopropyl m yrisratc 
O leic acid (OA) 
O A/ PG ( I: I) 
OA / PG(1 :3) 
OA / PG ( I: 14.5) 
Octanol (OCT ) 
OCT/ PG (I : I) 
' Contro l Au x of 7 x 10- 3 I1l g/cmoh. 
· Va lues fro m 161. 
'Va lues fro m 151. 
Vehicle Alone 
1. 1 
2.6 
1. 6 
2.4 
19.0 
99.0 
162.0 
122.0 
11 3.0 
122. 0 
no 
Skin Pretrearmcnt 
5- FlllorollrJcillV chicle Sa licy li c Acid / Vehi cle" 
19.0 
7.7 
24.0 
4.4 
34.0 
96.0 
92.0 
1030 
85.0 
104.0 
69.0 
22.0 
83.0 
162.0 
320.0 
T heophyll ine/Vehicle' 
2.0 
2.4 
2. 1 
3. 4 
45.U 
193.0 
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The v'ehicles chosen for the current study include some com-
monly found in topical formulations (e.g., lPM , EG, PG), some 
that act as penetration enh ancers (e.g., DFM, OA), and OCT, 
which mimics skin properties and is used as a model for skin in 
determinations of partition coefficients, T he effect of skin pre-
trea tment with mixed vehicles containing various amounts ofOA 
and PG were investiga ted because of previous reports by Cooper 
and coworkers [14,15] that the addition of O A to PG to make a 
mixed vehicle could increase transport of drugs such as salicylic 
acid or acyclovir over ei ther vehicl e alone. 
Our resu lts show 3 classes of vehicle effects on subseq uent 
T/PG flu x. Dimethylformamide, PG, EG, and FORM vehicles 
alone had no significant effect over control va lues. Oleic acid , 
OA/PG mixed vehicles, OCT, and OCT/PG had the greatest 
effects , and IPM was intermediate in its effect on T/PG flu x. The 
effect of having 5-FU in the vehicles for the skin pretreatment 
led to significantly enhanced flu x of the T IPG for vehicles that 
had no effect when applied alone. This is parti cularl y notable for 
5-FU in DMF or EG compared w ith pretreatment w ith those 
vehicl es alone. This suggests th at 5-FU itself may be affecting 
the skin barrier, but this effect is seen onl y w hen the vehicle itself 
has minimal effect. The nonpolar agen ts OA and OCT, applied 
either alone or in mixed vehicles with PG for skin pretreatment, 
affected the skin barrier to the extent that subsequent application 
of theophylline in PG to the skin had a flu x 30-60 times the effect 
, ofPG pretreatment alone. This suggests that OA and OCT have 
a profound effect on the barrier function that is not entirely due 
to the similarity in solubility parameters of th ese vehicl es or mix-
tures of vehicles to that of skin [5] , It may be that the vehicle 
itself or the functional groups on the vehicle are interactin g with 
the stratum corn eum to change the barrier properties [5]. Inter-
estin gly, skin pretreatment w ith 5-FU in OA, OCT, or mixed 
vehicles led to lower T IPG flu xes th an with those vehicles alone, 
It is unclear why this occurred, although we speculate that 5-
FU-veh'icle interactions make a difference. 
The results show that pre trea tment of hairl ess mouse skin in a 
diffusion cell system with a vehicle alone or a drug in those same 
vehicles can 'greatly increase the flu x through the skin of a sub-
sequently applied drug. T hese results indicate that not only the 
vehicle itself, but also the drug (5-FU, salicylic acid , or theoph-
ylline) preapplied to the skin can alter the penetration barrier for 
a later application of the same (in the case of theoph ylline) or a 
different drug. This effect does not appea r to be the result of a 
stratum corneum epidermal reservoir [1 6], since the enhancemen t 
is seen with 5-FU or sa licylic acid preapplication as well as w ith 
theophylline. The resu lts also show that enhanced dermal delivery 
using various penetration enhancers such as OA in PG may result 
from damage to the skin in the hairless mouse diffusion cell model. 
Such damage to the hairless mouse skin by vehicle application 
was no t evident at the light microscopic level r5] but scanning 
electron microscopic study of the stratum corneum, electri cal 
resistance measurement, or biochemical analysi s of the stratum 
corneum after vehicle treatment may help to clarify how the 
barrier is altered by different vehicles. The effects of the vehicles 
in compromising barrier integrity may not be as pronounced 
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w hen the vehicles are applied to human skin , and further work 
in this area using human skin is under way, Finall y, these results 
reemph asize the importance of experiments w ith second drug 
applications in studies th at purport to show penetration enhance-
ment. O bviousl y, penetra tion enhancemen t at the expense of even 
reversible damage to th e skin barrier is not always an acceptable 
clinical compromise, 
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